Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome
Articles > Article · 2011
Authors: Baris Akinci, Aygül ÇELTİK, Faize YÜKSEL, Sinan Genc, Serkan Yener, Mustafa Secil, Mehmet Ali ÖZCAN, Sena Yesil
DIABETES RESEARCH AND CLINICAL PRACTICE, Journal Indexed in SCI Expanded, International, 2011, vol 91, pp 26-31
DOI: 10.1016/j.diabres.2010.09.028
Summary
Osteoprotegerin (OPG), a novel soluble member of tumour necrosis factor receptor superfamily, has been shown to link cardiovascular disorders. The aim of this study is to investigate the potential relationship between serum OPG levels, cardiovascular risk factors and metabolic syndrome in a relatively large group of women with previous GDM.